The authors would like to thank Charles River Germany for providing CD-1 mice. We also thank Robin Schneider and the staff of the central biological laboratory for support in housing mice. We kindly thank Flora Nicholls for excellent technical assistance and Professor Kurt Burki for generously providing research facilities and resources.

The animal experiment was approved by the Cantonal Veterinary Office (Zurich, Switzerland). Housing and experimental procedures were in accordance with Swiss Animal Protection law and conform to the European Directive on the Protection of Animals Used for Scientific Purposes (DIRECTIVE 2010/63/EU OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 22 September 2010).
1. Pre-operative considerations
1.1 Mice: housing requirements, general condition and health monitoring
It is recommended that mice delivered from vendors or transferred from external rodent colonies should arrive at the housing facility at least two weeks prior to surgery. This period should allow the animals to adapt to the new environment and facility-specific housing conditions. Mice, as social living animals, should be housed in compatible groups during this adaptation period. For monitoring an individual&#39;s level of food and water consumption, each mouse is housed singly from 3 days before surgery until 10 days after surgical transmitter implantation. The time line for establishing telemetric-transmitter-bearing mice is shown in Figure 1. It is crucial that the animals come to surgery in good health and condition. Therefore, before surgery, animals should be monitored once per day for 2-3 days concerning general condition (appearance, posture, spontaneous behavior) as well as for body weight, food and water consumption. These data are documented on a medical record (general condition and health monitoring data sheet, Table 1) to establish individual baseline levels of general condition and overall health and wellbeing. Any animals showing symptoms of disease or impaired general condition before surgery should be excluded from the experiment.
After the last health check or directly prior surgery, in order to shave the animals for surgery, mice are anesthetized briefly in a small (8x8x8cm) Perspex chamber using sevoflurane (8%) or isoflurane (5%) in pure oxygen (600 mL/min). Shaving the animals one day before surgery prevents hair stubbles in the operating field. After loss of the righting reflex, the mouse is taken out of the chamber and the anterior neck and abdominal hair is clipped with the animal lying in dorsal recumbence; anesthesia is maintained for approximately 5 minutes with a nose mask with sevoflurane 3-4% or isoflurane 1.5-3% in pure oxygen at a flow rate of 600 mL/min. After clipping the hair, the animals are allowed to awaken and are then brought back to their home cage.
2. Implantation
2.1 Operating environment, preparation of the telemetric transmitter
On the day of implantation, all procedures regarding transmitter preparation and surgery are carried out on a work bench with a laminar flow hood equipped with a surgical microscope. Aseptic conditions are assured by the use of autoclaved instruments and sterilized materials and by disinfecting the work bench7. Prior to implantation, the telemetric transmitters (ETA-F10, Data Sciences International, St. Paul, MN, USA) are first prepared. After removing from their sterile package, the leads of the transmitter are shortened to a length appropriate for the size of the mouse to be implanted. In the majority of adult outbred or inbred mice, the red electrode may be shortened to approximately 42 mm and the white/colourless electrode to a length of approximately 55 mm. Insulation tubing is removed from the distal (sensory) part of the leads: approximately 20 mm of tubing is removed from the red electrode, approximately 10 mm of tubing is removed from the white/colourless electrode. The distal part of each electrode (which is now without tubing) is formed into a loop by fixing the end with thin silk sutures (PERMA-Handseide, 6-0, Ethicon, Norderstedt, Germany). After preparing the electrodes, the transmitter is placed in warm sterile saline ready to be implanted when the animal is anesthetized and surgically prepared.
2.2 Anesthesia
At 5-10 minutes before induction of inhalation anesthesia, a mixture of midazolam (4 mg/kg) and fentanyl (0.04 mg/kg) are administered subcutaneously as premedication, thus providing sedation and pre-emptive analgesia. General inhalation anesthesia is induced by placing the animal in the induction chamber and introducing the volatile anesthetic agent (sevoflurane 8% or isoflurane 5% in pure oxygen 600 ml/min). When the animal shows loss of the righting reflex it is transferred to the work bench under the laminar flow hood, and placed in dorsal recumbence on a specially designed metal plate fitted with a nose mask and tubing from the anesthesia apparatus. Anesthesia is maintained by spontaneous breathing (sevoflurane 3-4% or isoflurane 1.5-3% in pure oxygen at a flow rate of 600 mL/min). During anesthesia, the animal&#39;s eyes are protected with ointment (Vitamin A, Baush &#38; Lomb, Steinhausen, Switzerland). While lying on the metal plate the animal is warmed by the water-bath heated surface (39&#176;C +/-1) of the work bench.
2.3 Surgery
The skin of the anterior neck and abdominal region is disinfected for 5 minutes with 70% ethanol, chlorhexidine or iodine using a soaked cotton swab. A 1- to 1.5-cm-long incision in the skin is made from the lower thorax along the midline to the abdomen. The negative (white/colourless) lead is tunnelled subcutaneously from the thorax to the neck, where a small incision (&#8804;0.5 cm) is made in the longitudinal direction. The skin and underlying tissues are prepared to make space for the fixation of the wire loop of the electrode. The wire loop is fixed between the muscles located to the right of the trachea, using two thin silk sutures (PERMA-Handseide, 6-0, Ethicon, Norderstedt, Germany). The wound in the neck is then closed with absorbable sutures (VICRYL 6-0, Ethicon, Norderstedt, Germany) in layers. The abdominal wall is then opened at the linea alba and the body of the telemetric transmitter is placed into the abdominal cavity of the mouse. The wire loop of the positive (red) electrode is sutured to the xiphoid process with silk sutures in such a way that it lies between the liver and the diaphragm in the left upper abdominal region (Figure 2). Then, the muscle layers of the abdominal region are closed with absorbable sutures (VICRYL 6-0, Ethicon, Norderstedt, Germany). Before finally closing the abdominal wall, a mixture of Sulfadoxin and Trimethoprim [(30 mg/kg and 6 mg/kg, respectively; dissolved in 1 mL of saline (0.9%) and at approximately body temperature (38-39&#176;C)] is injected into the abdominal cavity for the purposes of anti-infective prophylaxis and to support fluid homeostasis. Finally, the skin of the abdominal region is restored with staples (Precise, 3 M Health Care, St. Paul, MN, USA) or intracutaneous, running, absorbable sutures (VICRYL 6-0, Ethicon, Norderstedt, Germany).
3. Post-operative care
After completion of surgery and anesthesia, 0.1 mg/kg of buprenorphine (Temgesic, Essex Chemie AG, Lucerne, Switzerland) and 5 mg/kg of meloxicam (Metacam, Boehringer Ingelheim, Basel, Switzerland) is administered subcutaneously for pain treatment, and the animals are left on the warm (39&#176;C +/-1) surface of the work bench to recover for approximately 2h. Together with pain relief (twice daily: buprenorphine, 0.1 mg/kg and meloxicam 5 mg/kg), supportive therapy consisting of 300 &#956;L glucose (5%) and 300 &#956;L saline (0.9%) warmed to body temperature, is injected subcutaneously twice daily for 4 days. For further recovery support, it is worthwhile providing the animals with an additional drinking bottle containing 15% glucose solution. During the recovery period of 4-10 days, it is recommended that the animals are kept warm. Therefore, in our case, the mice are housed in a warming cabinet (30&#176;C +/- 1). Monitoring of general condition and body weight, as well as food and water consumption, is performed once daily according to the general condition and health monitoring data sheet (Table 1) for 10 days post-operatively. Humane endpoints, i.e. the sacrifice of an animal to avoid unnecessary suffering and pain if progression of recovery is unsatisfactory, are realised under the following conditions:
<ol class="lroman">
	<li>If in poor general condition, i.e. the animal is substantially apathetic (no movement after being touched/pushed) and its body surface feels cold despite warming, the animal should be euthanatized immediately. </li>
	<li>If, on day 4 after transmitter implantation, the animal shows clear signs of apathy, is extremely aggressive or does not show any food intake, it should be euthanatized immediately.</li>
	<li>On day 8 after transmitter implantation, the animal has to display a clear increase in body weight in comparison to the preceding post-operative days. Moreover, it has to consume at least 80% of the pre-operative daily food intake. If one of these conditions is not met, the animal should be euthanatized immediately.</li>
</ol>
At 10 days after implantation, the animal is transferred back to the animal room under standard housing conditions. In case staples have been used, these should be removed 7-10 days after surgery; absorbable sutures have not to be removed. Mice should be housed in compatible groups to allow social interaction and to prevent the adverse effects of long-term individual housing, which can have substantial impacts on the read-out of subsequent experiments8, 9. Mice should have a period of at least 4 weeks convalescence after transmitter implantation before the first experiment is conducted and data acquisition begins.
4. Data acquisition
Data collection is initiated by touching the animal with a magnet, whereupon the transmitter is switched on. Dataquest A.R.T. Software (Data Sciences International, St. Paul, MN, USA) coordinates the detection, collection, analysis and graphical presentation (in the form of wave forms) of signals from one or more animals. The Acquisition program collects data signals sent to the computer from the converters and receivers via a Data Exchange Matrix (Data Sciences International). This program can either collect data for a specific length of time at regular intervals or sample continuously and save the data on the computer&#39;s hard drive. As the range and the quality of the emitted signal depends strongly on the material composition of the cage and surrounding equipment (e.g. metal vs. plastic), it is suggested that the receiver plate is placed as close to the animal as possible, e.g. under the animals&#39; cage or above the experimental area, e.g. laboratory bench or treadmill. It is recommended that the correct configuration of the recording and data transmission system be checked by making a short examination of real-time measurements in continuous sampling mode. After the data have been gathered and stored, they can be plotted, listed and analysed for a variety of different parameters using the Analysis program. Details of the configuration of the recording system (e.g. defining the sampling modus), and analysis software (e.g. for heart rate variability parameters, PQ interval and QT interval established from biopotential/ECG curves) can be found in the manufacturer&#39;s manuals. Valuable hints for biometric planning and statistical methods useful for telemetric data acquisition and interpretation are published elsewhere3.
5. Representative Results:
An overall scheme of the described procedure is shown in Figure 1. The position of the implanted transmitter, including the location of the electrodes for obtaining biopotentials from the heart (one-lead ECG) is shown in Figure 2. Examples of raw data from short term biopotential curves (one-lead ECG), and long-term heart rate, core body temperature and locomotor activity recordings of individual mice are given in Figure 3 and Figure 4, respectively. Figure 5 gives an example of published data from long-term measurements in groups of mice after an experiment. Several other parameters can be established from the biopotentials curves. Examples for presentation of heart rate variability parameters5, QT interval and PQ interval10, 11 are published elsewhere.
Table 1. General condition and health monitoring data sheet. <a href="https://www.jove.com/files/ftp_upload/3260/3260ConditionMonitoringDataSheet.doc">Click here to download the sheet.</a> This template facilitates monitoring of an individual mouse&#39;s general condition and health. Baseline examination of an animal&#39;s appearance, posture, and spontaneous behavior, as well as determination of body weight, and food and water consumption must be established before implantation surgery once per day for 3 days. Comparison of baseline determinations with those obtained daily for 10 days after surgery serve to assess the progression of post-operative recovery. In addition, post-operative care and pain treatment are well documented in the form of a medical record. Instructions on humane endpoints are given in order to facilitate decisions on whether a mouse should be sacrificed to prevent unnecessary pain and suffering if the animal does not meet the criteria for fast recovery after implantation.
<img alt="Figure 1" src="/files/ftp_upload/3260/3260fig1.jpg" /> 
Figure 1. Schedule for establishing telemetric-transmitter-bearing mice. Chronological order of procedures relating to the implantation of a transmitter showing the time points at which a mouse can be used for experiments and data acquisition.
<img alt="Figure 2" src="/files/ftp_upload/3260/3260fig2.jpg" /> 
Figure 2. Radiograph/sketch showing location of the implanted telemetry transmitter. The body of the transmitter is positioned in the abdominal cavity. The positive lead is formed into a wire loop and fixed to the xiphoid process with sutures. The negative lead is tunneled subcutaneously from the thorax to the neck and fixed as a wire loop between the muscles directly next to the trachea. The radiograph is taken from the authors&#39; previous publication in Laboratory Animals9.
<img alt="Figure 3" src="/files/ftp_upload/3260/3260fig3.jpg" /> 
Figure 3. Biopotential curves. Raw printout of one-lead ECG curves from a conscious mouse and of the same animal under inhalation anesthesia with sevoflurane. Heart rate is calculated automatically by the telemetry system. The 3-second sequence recorded under anesthesia indicates a heart rate of 440 bpm. The curve recorded in the conscious mouse shows a heart rate of 660 bpm, which falls within the expected range for heart rate during moderate physical activities such as grooming or eating. From biopotential/one-lead ECG curves, heart rate variability parameters, interbeat interval, and PQ and QT intervals can be established with use of the manufacturer&#39;s software.
<img alt="Figure 4" src="/files/ftp_upload/3260/3260fig4.jpg" /> 
Figure 4. Raw data from long-term measurements in healthy and diseased mice. Heart rate (bpm), core body temperature (&#176;C) and locomotor activity (counts) are measured while mice are housed individually in their home cage without any disturbance from man or experimental procedures. Heart rate is recorded for 30 seconds every 5 minutes (sampling frequency 1000 Hz). Core body temperature is sampled for 10 seconds every 5 minutes. Locomotor activity is recorded continuously and stored at 5 minute intervals. Five-minute data points are traced for 6.5 days. The telemetric measurements are recorded from three mice with differing bodily conditions. The healthy mouse shows a clear circadian rhythm with normal increases in physiological values and locomotor activity behavior during the dark (night) phase. In contrast, after major surgery, heart rate is increased, particularly in the daylight phase, and locomotor activity is depressed. The third mouse suffered from chronic tumor disease-its circadian rhythm of heart rate and core body temperature appears flattened, and locomotor activity is diminished. Representative data of heart rate measurements (normal values and after major surgery) are taken from the authors&#39; previous publication in Altex12.
<img alt="Figure 5" src="/files/ftp_upload/3260/3260fig5.jpg" /> 
Figure 5. Example of presentation of results from long-term telemetry measurements after an experiment. The figure is taken from the authors&#39; previous publication in Laboratory Animals1. As an exemplary experiment, a 50-minute isoflurane or sevoflurane anesthesia was performed. The long-term impact of the anesthetics on heart rate, core body temperature and locomotor activity after the animals were awake was compared. Using 16 transmitter-implanted mice, telemetric data were recorded in eight mice per anesthetic while the animals were single-housed and allowed to roam freely in their home cages. For analysis of long-term postanesthetic effects, we took into account that values vary greatly during a 24-h cycle since mice are active mainly at night. Therefore, the means of the telemetric values for each animal were calculated separately for the night (12 h dark) and day (12 h light) phases. An individual&#39;s normal values were established by calculating means from the three days prior to anesthesia. For each day after anesthesia, the mean of the dark and light phase was compared with the individual&#39;s normal values, resulting in delta values. Thus, delta values represent deviation from normal values (established prior to anesthesia) at the corresponding 12 h day and night time. Columns represent the mean from eight mice; bars indicate standard deviation. Asterisks indicate significance at P &#8804;0.05 (One-way analysis of variance for comparison of group means at each of the four days after anesthesia with normal values).

<ol>
	<li>Cesarovic, N. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Isoflurane+and+sevoflurane+provide+equally+effective+anesthesia+in+laboratory+mice.">Isoflurane and sevoflurane provide equally effective anesthesia in laboratory mice.</a> Lab. Anim. 44, 329-336 (2010).</li><li>Gross, V., Luft, F. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Exercising+restraint+in+measuring+blood+pressure+in+conscious+mice.">Exercising restraint in measuring blood pressure in conscious mice.</a> Hypertension. 41, 879-881 (2003).</li><li>Kramer, K., Kinter, L. B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Evaluation+and+applications+of+radiotelemetry+in+small+laboratory+animals.">Evaluation and applications of radiotelemetry in small laboratory animals.</a> Physiol. Genomics. 13, 197-205 (2003).</li><li>Kramer, K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Use+of+telemetry+to+record+electrocardiogram+and+heart+rate+in+freely+moving+mice.">Use of telemetry to record electrocardiogram and heart rate in freely moving mice.</a> J. Pharmacol. Toxicol. Methods. 30, 209-215 (1993).</li><li>Arras, M., Rettich, A., Cinelli, P., Kasermann, H. P., Burki, K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Assessment+of+post-laparotomy+pain+in+laboratory+mice+by+telemetric+recording+of+heart+rate+and+heart+rate+variability.">Assessment of post-laparotomy pain in laboratory mice by telemetric recording of heart rate and heart rate variability.</a> BMC. Vet. Res. 3, 16-16 (2007).</li><li>Schuler, B., Rettich, A., Vogel, J., Gassmann, ., Arras, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Optimized+surgical+techniques+and+postoperative+care+improve+survival+rates+and+permit+accurate+telemetric+recording+in+exercising+mice.">Optimized surgical techniques and postoperative care improve survival rates and permit accurate telemetric recording in exercising mice.</a> BMC. Vet. Res. 5, 28-28 (2009).</li><li>Pritchett-Corning, K. R., Mulder, G. B., Luo, Y., White, W. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Principles+of+Rodent+Surgery+for+the+New+Surgeon.">Principles of Rodent Surgery for the New Surgeon.</a> J. Vis. Exp. (47), e2586-e2586 (2011).</li><li>Rettich, A., Kasermann, H. P., Pelczar, P., Burki, K., Arras, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+physiological+and+behavioral+impact+of+sensory+contact+among+unfamiliar+adult+mice+in+the+laboratory.">The physiological and behavioral impact of sensory contact among unfamiliar adult mice in the laboratory.</a> J. Appl. Anim. Welf. Sci. 9, 277-288 (2006).</li><li>Spani, D., Arras, M., Konig, B., Rulicke, T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Higher+heart+rate+of+laboratory+mice+housed+individually+vs+in+pairs.">Higher heart rate of laboratory mice housed individually vs in pairs.</a> Lab. Anim. 37, 54-62 (2003).</li><li>Zeller, A., Arras, M., Jurd, R., Rudolph, U. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mapping+the+contribution+of+beta3-containing+GABAA+receptors+to+volatile+and+intravenous+general+anesthetic+actions.">Mapping the contribution of beta3-containing GABAA receptors to volatile and intravenous general anesthetic actions.</a> BMC. Pharmacol. 7, 2-2 (2007).</li><li>Zeller, A., Arras, M., Jurd, R., Rudolph, U. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Identification+of+a+molecular+target+mediating+the+general+anesthetic+actions+of+pentobarbital.">Identification of a molecular target mediating the general anesthetic actions of pentobarbital.</a> Mol. Pharmacol. 71, 852-859 (2007).</li><li>Arras, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Improvement+of+pain+therapy+in+laboratory+mice.">Improvement of pain therapy in laboratory mice.</a> Altex. 24, 6-8 (2007).</li></ol>

No conflicts of interest declared.

Radiotelemetry is a powerful alternative to conventional methods of measurement of physiological parameters in biomedical research. High-quality telemetry systems consisting of implantable transmitters, receivers and data acquisition and analysis hardware and software are now commercially available, even for animals as small as mice. Telemetry represents the only technique currently available for data collection from unrestrained, freely moving mice. By using this method, it is now possible to gather data continuously and/or for longer periods of time from animals residing in their own familiar environment, thus minimizing the stress to the animals and consequent experimental artifacts. The form and position of the leads has been optimized in order to obtain signals even during fast movements (e.g. struggling, running, fighting) or in an upright posture9. Thus, accurate measurements can be obtained during experiments, e.g. during anesthesia, stress induction, while running on a treadmill, during behavioral experiments, during infection experiments, and many other experimental situations.
However, in order to obtain reliable, reproducible and artifact-free data, it is crucial to exclude environmental influences, and we draw particular attention to the importance of standardized conditions. It is recommended that the room is isolated from electronic and acoustic noise, including ultrasonic sound, to which mice are particularly sensitive. In addition, no disturbances, such as visitors or unrelated experimental procedures, should be allowed when conducting measurements. To avoid interfering influences (particularly in case of home cage measurements), all necessary husbandry procedures should be completed in the room before starting each measurement. In addition, the housing of mice-particularly if males are used-in groups or individually can have an impact on the measurements and must be considered when planning experiments9. Also, the mice must be healthy and free of murine pathogens, since latent or manifest infections, as well as diseases or any other health impairments, can have considerable influence on physiological parameters and activity behavior. Accordingly, mice should recover fully after implantation and be given sufficient time to adapt to bearing the transmitter before starting any experiments.
Data collection by radiotelemetry in mice requires preliminary surgical implantation of the telemetry transmitter. This should be performed only by trained personnel with surgical skills in order to minimize tissue trauma and subsequent pain and distress. For experimenters holding basic or even advanced (micro-) surgical skills, it is recommended to perform the first trials in fresh mouse cadavers using training implants (i.e., dummies, provided by the manufacturer) to establish the procedures and become familiar with the specifics of this kind of surgery. After such training, most experimenters would be capable to implant this type of transmitters with success and would reach a useful proficiency after a few implantations.
Aseptic conditions should be maintained during surgery to keep the microbiological burden and the risk of infections low. However, if there are doubts that asepsis was breached because of some specific, sterility conflicting conditions in mice (e.g., cooling effect of extensive hair clipping and disinfection, impracticality of bandages to protect the wounds). Anti-infective prophylaxis should be administered during the implantation. Well-tailored analgesic treatment and a clearly defined monitoring plan as well as adequate post-operative care play a crucial role in the satisfactory outcome of the experiment.
Overall, the surgical implantation of a telemetric transmitter in mice will be stressful for the animal. In particular, if genetic modification in specific mouse lines influences the phenotype and impairs the animals&#39; bodily condition, complications in the peri-operative time frame and increased death rates after implantation might be a risk. To avoid unnecessary suffering, individuals exhibiting unsatisfactory recovery or prolonged convalescence should be released from the experiment and sacrificed before reaching a moribund stage. For this purpose, a data sheet (Table 1: general condition and health monitoring data sheet) facilitating the systematic monitoring of critical symptoms and providing advice on humane endpoints has been established. Thus, recovery is documented in the style of a medical record or a laboratory journal, which makes the conducting of this methodology (i.e. implantation procedure and post-operative recovery) transparent to the relevant authorities and animal welfare bodies responsible for animal experimentation (e.g., IACUC).

Corrections in the Protocol and Discussion sections have been made to: Implantation of Radiotelemetry Transmitters Yielding Data on ECG, Heart Rate, Core Body Temperature and Activity in Free-moving Laboratory Mice
Step 1.2 in the Protocol has been updated from:
1.2 Hair clipping at one day prior to surgery
The day prior to implantation, in order to shave the animals for surgery, mice are anesthetized briefly in a small (8x8x8cm) Perspex chamber using sevoflurane (8%) or isoflurane (5%) in pure oxygen (600 mL/min). After loss of the righting reflex, the mouse is taken out of the chamber and the anterior neck and abdominal hair is clipped with the animal lying in dorsal recumbence; anesthesia is maintained for approximately 5 minutes with a nose mask with sevoflurane 3-4% or isoflurane 1.5-3% in pure oxygen at a flow rate of 600 mL/min. After clipping the hair, the animals are allowed to awaken and are then brought back to their home cage.
to:
After the last health check or directly prior surgery, in order to shave the animals for surgery, mice are anesthetized briefly in a small (8x8x8cm) Perspex chamber using sevoflurane (8%) or isoflurane (5%) in pure oxygen (600 mL/min). Shaving the animals one day before surgery prevents hair stubbles in the operating field. After loss of the righting reflex, the mouse is taken out of the chamber and the anterior neck and abdominal hair is clipped with the animal lying in dorsal recumbence; anesthesia is maintained for approximately 5 minutes with a nose mask with sevoflurane 3-4% or isoflurane 1.5-3% in pure oxygen at a flow rate of 600 mL/min. After clipping the hair, the animals are allowed to awaken and are then brought back to their home cage.
Step 2.3 in the Protocol has been updated from:
2.3 Surgery
The skin of the anterior neck and abdominal region is disinfected with 70% ethanol. A 1- to 1.5-cm-long incision in the skin is made from the lower thorax along the midline to the abdomen. The negative (white/colourless) lead is tunnelled subcutaneously from the thorax to the neck, where a small incision (&#8804;0.5 cm) is made in the longitudinal direction. The skin and underlying tissues are prepared to make space for the fixation of the wire loop of the electrode. The wire loop is fixed between the muscles located to the right of the trachea, using two thin silk sutures (PERMA-Handseide, 6-0, Ethicon, Norderstedt, Germany). The wound in the neck is then closed with absorbable sutures (VICRYL 6-0, Ethicon, Norderstedt, Germany) in layers. The abdominal wall is then opened at the linea alba and the body of the telemetric transmitter is placed into the abdominal cavity of the mouse. The wire loop of the positive (red) electrode is sutured to the xiphoid process with silk sutures in such a way that it lies between the liver and the diaphragm in the left upper abdominal region (Figure 2). Then, the muscle layers of the abdominal region are closed with absorbable sutures (VICRYL 6-0, Ethicon, Norderstedt, Germany). Before finally closing the abdominal wall, a mixture of Sulfadoxin and Trimethoprim [(30 mg/kg and 6 mg/kg, respectively; dissolved in 1 mL of saline (0.9%) and at approximately body temperature (38-39&#176;C)] is injected into the abdominal cavity for the purposes of anti-infective prophylaxis and to support fluid homeostasis. Finally, the skin of the abdominal region is restored with staples (Precise, 3 M Health Care, St. Paul, MN, USA).
to:
2.3 Surgery
The skin of the anterior neck and abdominal region is disinfected for 5 minutes with 70% ethanol, chlorhexidine or iodine using a soaked cotton swab. A 1- to 1.5-cm-long incision in the skin is made from the lower thorax along the midline to the abdomen. The negative (white/colourless) lead is tunnelled subcutaneously from the thorax to the neck, where a small incision (&#8804;0.5 cm) is made in the longitudinal direction. The skin and underlying tissues are prepared to make space for the fixation of the wire loop of the electrode. The wire loop is fixed between the muscles located to the right of the trachea, using two thin silk sutures (PERMA-Handseide, 6-0, Ethicon, Norderstedt, Germany). The wound in the neck is then closed with absorbable sutures (VICRYL 6-0, Ethicon, Norderstedt, Germany) in layers. The abdominal wall is then opened at the linea alba and the body of the telemetric transmitter is placed into the abdominal cavity of the mouse. The wire loop of the positive (red) electrode is sutured to the xiphoid process with silk sutures in such a way that it lies between the liver and the diaphragm in the left upper abdominal region (Figure 2). Then, the muscle layers of the abdominal region are closed with absorbable sutures (VICRYL 6-0, Ethicon, Norderstedt, Germany). Before finally closing the abdominal wall, a mixture of Sulfadoxin and Trimethoprim [(30 mg/kg and 6 mg/kg, respectively; dissolved in 1 mL of saline (0.9%) and at approximately body temperature (38-39&#176;C)] is injected into the abdominal cavity for the purposes of anti-infective prophylaxis and to support fluid homeostasis. Finally, the skin of the abdominal region is restored with staples (Precise, 3 M Health Care, St. Paul, MN, USA) or intracutaneous, running, absorbable sutures (VICRYL 6-0, Ethicon, Norderstedt, Germany).

Step 3 in the Protocol has been updated from:
3. Post-operative care
After completion of surgery and anesthesia, 0.1 mg/kg of buprenorphine (Temgesic, Essex Chemie AG, Lucerne, Switzerland) and 5 mg/kg of meloxicam (Metacam, Boehringer Ingelheim, Basel, Switzerland) is administered subcutaneously for pain treatment, and the animals are left on the warm (39&#176;C +/-1) surface of the work bench to recover for approximately 2h. Together with pain relief (twice daily: buprenorphine, 0.1 mg/kg and meloxicam 5 mg/kg), supportive therapy consisting of 300 &#956;L glucose (5%) and 300 &#956;L saline (0.9%) warmed to body temperature, is applied subcutaneously twice daily for 4 days. For further recovery support, it is worthwhile providing the animals with an additional drinking bottle containing 15% glucose solution During the recovery period of 4-10 days, it is recommended that the animals are kept warm. Therefore, in our case, the mice are housed in a warming cabinet (30&#176;C +/- 1). Monitoring of general condition and body weight, as well as food and water consumption, is performed once daily according to the general condition and health monitoring data sheet (Table 1) for 10 days post-operatively. Humane endpoints, i.e. the sacrifice of an animal to avoid unnecessary suffering and pain if progression of recovery is unsatisfactory, are realised under the following conditions:
i. If in poor general condition, i.e. the animal is substantially apathetic (no movement after being touched/pushed) and its body surface feels cold despite warming, the animal should be euthanatized immediately
ii. If, on day 4 after transmitter implantation, the animal shows clear signs of apathy, is extremely aggressive or does not show any food intake, it should be euthanatized immediately.
iii. On day 8 after transmitter implantation, the animal has to display a clear increase in body weight in comparison to the preceding post-operative days. Moreover, it has to consume at least 80% of the pre-operative daily food intake. If one of these conditions is not met, the animal should be euthanatized immediately.
At 10 days after implantation, the animal is transferred back to the animal room under standard housing conditions. Mice should be housed in compatible groups to allow social interaction and to prevent the adverse effects of long-term individual housing, which can have substantial impacts on the read-out of subsequent experiments8, 9. Mice should have a period of at least 4 weeks convalescence after transmitter implantation before the first experiment is conducted and data acquisition begins.
to:
After completion of surgery and anesthesia, 0.1 mg/kg of buprenorphine (Temgesic, Essex Chemie AG, Lucerne, Switzerland) and 5 mg/kg of meloxicam (Metacam, Boehringer Ingelheim, Basel, Switzerland) is administered subcutaneously for pain treatment, and the animals are left on the warm (39&#176;C +/-1) surface of the work bench to recover for approximately 2h. Together with pain relief (twice daily: buprenorphine, 0.1 mg/kg and meloxicam 5 mg/kg), supportive therapy consisting of 300 &#956;L glucose (5%) and 300 &#956;L saline (0.9%) warmed to body temperature, is injected subcutaneously twice daily for 4 days. For further recovery support, it is worthwhile providing the animals with an additional drinking bottle containing 15% glucose solution During the recovery period of 4-10 days, it is recommended that the animals are kept warm. Therefore, in our case, the mice are housed in a warming cabinet (30&#176;C +/- 1). Monitoring of general condition and body weight, as well as food and water consumption, is performed once daily according to the general condition and health monitoring data sheet (Table 1) for 10 days post-operatively. Humane endpoints, i.e. the sacrifice of an animal to avoid unnecessary suffering and pain if progression of recovery is unsatisfactory, are realised under the following conditions:
i. If in poor general condition, i.e. the animal is substantially apathetic (no movement after being touched/pushed) and its body surface feels cold despite warming, the animal should be euthanatized immediately
ii. If, on day 4 after transmitter implantation, the animal shows clear signs of apathy, is extremely aggressive or does not show any food intake, it should be euthanatized immediately.
iii. On day 8 after transmitter implantation, the animal has to display a clear increase in body weight in comparison to the preceding post-operative days. Moreover, it has to consume at least 80% of the pre-operative daily food intake. If one of these conditions is not met, the animal should be euthanatized immediately.
At 10 days after implantation, the animal is transferred back to the animal room under standard housing conditions. In case staples have been used, these should be removed 7-10 days after surgery; absorbable sutures have not to be removed. Mice should be housed in compatible groups to allow social interaction and to prevent the adverse effects of long-term individual housing, which can have substantial impacts on the read-out of subsequent experiments8, 9. Mice should have a period of at least 4 weeks convalescence after transmitter implantation before the first experiment is conducted and data acquisition begins.
The 4th paragraph in the Discussion has been updated from:
Aseptic conditions should be maintained during surgery to keep the microbiological burden and the risk of infections low. However, complete sterility cannot be provided because of some specific, sterility conflicting conditions in mice (e.g., cooling effect of extensive hair clipping and disinfection, impracticality of bandages to protect the wounds). Thus, anti-infective prophylaxis is administered during the implantation. Well tailored analgesic treatment and a clearly defined monitoring plan as well as adequate post-operative care play a crucial role in the satisfactory outcome of the experiment.
to:
Aseptic conditions should be maintained during surgery to keep the microbiological burden and the risk of infections low. However, if there are doubts that asepsis was breached because of some specific, sterility conflicting conditions in mice (e.g., cooling effect of extensive hair clipping and disinfection, impracticality of bandages to protect the wounds). Anti-infective prophylaxis should be administered during the implantation. Well-tailored analgesic treatment and a clearly defined monitoring plan as well as adequate post-operative care play a crucial role in the satisfactory outcome of the experiment.

Corrections in the Protocol and Discussion sections have been made to: Implantation of Radiotelemetry Transmitters Yielding Data on ECG, Heart Rate, Core Body Temperature and Activity in Free-moving Laboratory Mice

Erratum: Implantation of Radiotelemetry Transmitters Yielding Data on ECG, Heart Rate, Core Body Temperature and Activity in Free-moving Laboratory Mice

implantation of radiotelemetry transmitters yielding data on ecg, heart rate, core body temperature and activity in free-moving laboratory mice

The laboratory mouse is the animal species of choice for most biomedical research, in both the academic sphere and the pharmaceutical industry. Mice are a manageable size and relatively easy to house. These factors, together with the availability of a wealth of spontaneous and experimentally induced mutants, make laboratory mice ideally suited to a wide variety of research areas.
In cardiovascular, pharmacological and toxicological research, accurate measurement of parameters relating to the circulatory system of laboratory animals is often required. Determination of heart rate, heart rate variability, and duration of PQ and QT intervals are based on electrocardiogram (ECG) recordings. However, obtaining reliable ECG curves as well as physiological data such as core body temperature in mice can be difficult using conventional measurement techniques, which require connecting sensors and lead wires to a restrained, tethered, or even anaesthetized animal. Data obtained in this fashion must be interpreted with caution, as it is well known that restraining and anesthesia can have a major artifactual influence on physiological parameters1, 2.
Radiotelemetry enables data to be collected from conscious and untethered animals. Measurements can be conducted even in freely moving animals, and without requiring the investigator to be in the proximity of the animal. Thus, known sources of artifacts are avoided, and accurate and reliable measurements are assured. This methodology also reduces interanimal variability, thus reducing the number of animals used, rendering this technology the most humane method of monitoring physiological parameters in laboratory animals3, 4. Constant advancements in data acquisition technology and implant miniaturization mean that it is now possible to record physiological parameters and locomotor activity continuously and in realtime over longer periods such as hours, days or even weeks3, 5.
Here, we describe a surgical technique for implantation of a commercially available telemetry transmitter used for continuous measurements of core body temperature, locomotor activity and biopotential (i.e. onelead ECG), from which heart rate, heart rate variability, and PQ and QT intervals can be established in freeroaming, untethered mice. We also present pre-operative procedures and protocols for post-operative intensive care and pain treatment that improve recovery, well-being and survival rates in implanted mice5, 6.

Watch this Scientific Journal Video about Implantation of Radiotelemetry Transmitters Yielding Data on ECG, Heart Rate, Core Body Temperature and Activity in Free-moving Laboratory Mice at JoVE.com

Implantation of Radiotelemetry Transmitters Yielding Data on ECG, Heart Rate, Core Body Temperature and Activity in Free-moving Laboratory Mice

A surgical technique for implantation of commercially available telemetry transmitters used for continuous measurement of biopotential (one-lead ECG), heart rate, core body temperature and locomotor activity in freely moving mice is shown. Recommendations and protocols for post-operative care and pain relief, improving recovery, well being and survival rate are also presented.

The laboratory mouse is the animal species of choice for most biomedical research, in both the academic sphere and the pharmaceutical industry. Mice are a ...

implantation-radiotelemetry-transmitters-yielding-data-on-ecg-heart

Research

JoVE Journal

Medicine

40.3K Views.  University Hospital Zurich. A surgical technique for implantation of commercially available telemetry transmitters used for continuous measurement of biopotential (one-lead ECG), heart rate, core body temperature and locomotor activity in freely moving mice is shown. Recommendations and protocols for post-operative care and pain relief, improving recovery, well being and survival rate are also presented.

Video: Implantation of Radiotelemetry Transmitters Yielding Data on ECG, Heart Rate, Core Body Temperature and Activity in Free-moving Laboratory Mice

Implantation of a Carotid Cuff for Triggering Shear-stress Induced Atherosclerosis in Mice

It is widely accepted that alterations in vascular shear stress trigger the expression of inflammatory genes in endothelial cells and thereby induce atherosclerosis (reviewed in 1 and 2). The role of shear stress has been extensively studied in vitro investigating the influence of flow dynamics on cultured endothelial cells 1,3,4 and in vivo in larger animals and humans 1,5,6,7,8. However, highly reproducible small animal models allowing systematic investigation of the influence of shear stress on plaque development are rare. Recently, Nam et al. 9 introduced a mouse model in which the ligation of branches of the carotid artery creates a region of low and oscillatory flow. Although this model causes endothelial dysfunction and rapid formation of atherosclerotic lesions in hyperlipidemic mice, it cannot be excluded that the observed inflammatory response is, at least in part, a consequence of endothelial and/or vessel damage due to ligation.
In order to avoid such limitations, a shear stress modifying cuff has been developed based upon calculated fluid dynamics, whose cone shaped inner lumen was selected to create defined regions of low, high and oscillatory shear stress within the common carotid artery 10. By applying this model in Apolipoprotein E (ApoE) knockout mice fed a high cholesterol western type diet, vascular lesions develop upstream and downstream from the cuff. Their phenotype is correlated with the regional flow dynamics 11 as confirmed by in vivo Magnetic Resonance Imaging (MRI) 12: Low and laminar shear stress upstream of the cuff causes the formation of extensive plaques of a more vulnerable phenotype, whereas oscillatory shear stress downstream of the cuff induces stable atherosclerotic lesions 11. In those regions of high shear stress and high laminar flow within the cuff, typically no atherosclerotic plaques are observed.
 
In conclusion, the shear stress-modifying cuff procedure is a reliable surgical approach to produce phenotypically different atherosclerotic lesions in ApoE-deficient mice.

The constricting cuff presented in this article is designed to induce atherosclerosis in the murine common carotid artery. Due to the conical shape of its inner lumen the implanted cuff generates well-defined regions of low, high and oscillatory shear stress triggering the development of atherosclerotic lesions of different inflammatory phenotypes.

It is widely accepted that alterations in vascular shear stress trigger the expression of inflammatory genes in endothelial cells and thereby induce ...

Implantation of the Syncardia Total Artificial Heart

With advances in technology, the use of mechanical circulatory support devices for end stage heart failure has rapidly increased. The vast majority of such patients are generally well served by left ventricular assist devices (LVADs). However, a subset of patients with late stage biventricular failure or other significant anatomic lesions are not adequately treated by isolated left ventricular mechanical support. Examples of concomitant cardiac pathology that may be better treated by resection and TAH replacement includes: post infarction ventricular septal defect,&#160;aortic root aneurysm / dissection, cardiac allograft failure, massive ventricular thrombus, refractory malignant arrhythmias (independent of filling pressures), hypertrophic / restrictive cardiomyopathy, and complex congenital heart disease. Patients often present with cardiogenic shock and multi system organ dysfunction. Excision of both ventricles and orthotopic replacement with a total artificial heart (TAH) is an effective, albeit extreme, therapy for rapid restoration of blood flow and resuscitation. Perioperative management is focused on end organ resuscitation and physical rehabilitation. In addition to the usual concerns of infection, bleeding, and thromboembolism common to all mechanically supported patients, TAH patients face unique risks with regard to renal failure and anemia. Supplementation of the abrupt decrease in brain natriuretic peptide following ventriculectomy appears to have protective renal effects. Anemia following TAH implantation can be profound and persistent. Nonetheless, the anemia is generally well tolerated and transfusion are limited to avoid HLA sensitization. Until recently, TAH patients were confined as inpatients tethered to a 500 lb pneumatic console driver. Recent introduction of a backpack sized portable driver (currently under clinical trial) has enabled patients to be discharged home and even return to work. Despite the profound presentation of these sick patients, there is a 79-87% success in bridge to transplantation.

The purpose of this manuscript is to briefly review indications, management, and outcomes for the total artificial heart. Video operative techniques for device implantation are presented.

With advances in technology, the use of mechanical circulatory support devices for end stage heart failure has rapidly increased. The vast majority of ...

Echocardiographic Assessment of the Right Heart in Mice

Transgenic and toxic models of pulmonary arterial hypertension (PAH) are widely used to study the pathophysiology of PAH and to investigate potential therapies. Given the expense and time involved in creating animal models of disease, it is critical that researchers have tools to accurately assess phenotypic expression of disease. Right ventricular dysfunction is the major manifestation of pulmonary hypertension. Echocardiography is the mainstay of the noninvasive assessment of right ventricular function in rodent models and has the advantage of clear translation to humans in whom the same tool is used. Published echocardiography protocols in murine models of PAH are lacking.
In this article, we describe a protocol for assessing RV and pulmonary vascular function in a mouse model of PAH with a dominant negative BMPRII mutation; however, this protocol is applicable to any diseases affecting the pulmonary vasculature or right heart. We provide a detailed description of animal preparation, image acquisition and hemodynamic calculation of stroke volume, cardiac output and an estimate of pulmonary artery pressure.

This article provides a protocol for the echocardiographic assessment of right ventricular size and pulmonary hypertension in mice. Applications include phenotype determination and serial assessment in transgenic and toxin-induced mouse models of cardiomyopathy and pulmonary vascular disease.

Transgenic and toxic models of pulmonary arterial hypertension (PAH) are widely used to study the pathophysiology of PAH and to investigate potential ...

In utero Measurement of Heart Rate in Mouse by Noninvasive M-mode Echocardiography

Congenital heart disease (CHD) is the most frequent noninfectious cause of death at birth. The incidence of CHD ranges from 4 to 50/1,000 births (Disease and injury regional estimates, World Health Organization, 2004). Surgeries that often compromise the quality of life are required to correct heart defects, reminding us of the importance of finding the causes of CHD. Mutant mouse models and live imaging technology have become essential tools to study the etiology of this disease. Although advanced methods allow live imaging of abnormal hearts in embryos, the physiological and hemodynamic states of the latter are often compromised due to surgical and/or lengthy procedures. Noninvasive ultrasound imaging, however, can be used without surgically exposing the embryos, thereby maintaining their physiology. Herein, we use simple M-mode ultrasound to assess heart rates of embryos at E18.5 in utero. The detection of abnormal heart rates is indeed a good indicator of dysfunction of the heart and thus constitutes a first step in the identification of developmental defects that may lead to heart failure.

In utero Measurement of Heart Rate in Mouse by Noninvasive M-mode Echocardiography

Ultra-high frequency ultrasound is a powerful live imaging tool to examine cardiac abnormalities in small animals. Its noninvasiveness allows maintaining the physiologic state of embryos. Herein, we show the use of M-mode ultrasound to measure the heart rates of embryos at E18.5 in utero.

Congenital heart disease (CHD) is the most frequent noninfectious cause of death at birth. The incidence of CHD ranges from 4 to 50/1,000 births (Disease ...

Implantation of Total Artificial Heart in Congenital Heart Disease

In patients with end-stage heart failure (HF), a total artificial heart (TAH) may be implanted as a bridge to cardiac transplant. However, in congenital heart disease (CHD), the malformed heart presents a challenge to TAH implantation. 
In the case presented here, a 17 year-old patient with congenital transposition of the great arteries (CCTGA) experienced progressively worsening HF due to his congenital condition. He was hospitalized multiple times and received an implantable cardioverter defibrillator (ICD). However, his condition soon deteriorated to end-stage HF with multisystem organ failure. 
Due to the patient's grave clinical condition and the presence of complex cardiac lesions, the decision was made to proceed with a TAH. The abnormal arrangement of the patient's ventricles and great arteries required modifications to the TAH during implantation.
With the TAH in place, the patient was able to return home and regain strength and physical well-being while awaiting a donor heart. He was successfully bridged to heart transplantation 5 months after receiving the device. This report highlights the TAH is feasible even in patients with structurally abnormal hearts, with technical modification.

This is a case report of a patient with congenitally corrected transposition of the great arteries (CCTGA) who received a total artificial heart (TAH) as a bridge to heart transplant. The TAH was successfully implanted with modifications to accommodate the patient's congenitally malformed heart.

In patients with end-stage heart failure (HF), a total artificial heart (TAH) may be implanted as a bridge to cardiac transplant. However, in congenital ...

Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel

Severe thrombosis and its ischemic consequences such as myocardial infarction, pulmonary embolism and stroke are major worldwide health issues. The ferric chloride injury is now a well-established technique to rapidly and accurately induce the formation of thrombi in exposed veins or artery of small and large diameter. This model has played a key role in the study of the pathophysiology of thrombosis, in the discovery and validation of novel antithrombotic drugs and in the understanding of the mechanism of action of these new agents. Here, the implementation of this technique on a mesenteric vessel and carotid artery in mice is presented. The method describes how to label circulating leukocytes and platelets with a fluorescent dye and to observe, by intravital microscopy on the exposed mesentery, their accumulation at the injured vessel wall which leads to the formation of a thrombus. On the carotid artery, the occlusion caused by the clot formation is measured by monitoring the blood flow with a Doppler probe.

The FeCl3 induced thrombosis model in mice is described herein. A method to monitor thrombus growth by intravital microscopy observation on a mesenteric vessel and by blood flow measurement in the carotid artery is presented.

Severe thrombosis and its ischemic consequences such as myocardial infarction, pulmonary embolism and stroke are major worldwide health issues. The ferric ...

Heterotopic Cervical Heart Transplantation in Mice

The heterotopic cervical heart transplantation in mice is a valuable tool in transplant and cardiovascular research. The cuff technique greatly simplifies this model by avoiding challenging suture anastomoses of small vessels thereby reducing warm ischemia time. In comparison to abdominal graft implantation the cervical model is less invasive and the implanted graft is easily accessible for further follow-up examinations. Anastomoses are performed by pulling the ascending aorta of the graft over the cuff with the recipient&#8217;s common carotid artery and by pulling the main pulmonary artery over the cuff with the external jugular vein. Selection of appropriate cuff size and complete mobilization of the vessels are important for successful revascularization. Ischemia-reperfusion (I/R) injury can be minimized by perfusing the graft with a cardioplegic solution and by hypothermia. In this article, we provide technical details for a simplified and improved cuff technique, which should allow surgeons with basic microsurgical skills to perform the procedure with a high success rate.

The cuff technique shortens and facilitates the model of heterotopic cervical heart transplantation in mice by avoiding technically challenging suture anastomoses of small vessels. The technical details shown in this video paper should allow researches to establish this model in their laboratories.

The heterotopic cervical heart transplantation in mice is a valuable tool in transplant and cardiovascular research. The cuff technique greatly simplifies ...

In Vitro and In Vivo Detection of Mitophagy in Human Cells, C. Elegans, and Mice

Mitochondria are the powerhouses of cells and produce cellular energy in the form of ATP. Mitochondrial dysfunction contributes to biological aging and a wide variety of disorders including metabolic diseases, premature aging syndromes, and neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD). Maintenance of mitochondrial health depends on mitochondrial biogenesis and the efficient clearance of dysfunctional mitochondria through mitophagy. Experimental methods to accurately detect autophagy/mitophagy, especially in animal models, have been challenging to develop. Recent progress towards the understanding of the molecular mechanisms of mitophagy has enabled the development of novel mitophagy detection techniques. Here, we introduce several versatile techniques to monitor mitophagy in human cells, Caenorhabditis elegans (e.g., Rosella and DCT-1/ LGG-1 strains), and mice (mt-Keima). A combination of these mitophagy detection techniques, including cross-species evaluation, will improve the accuracy of mitophagy measurements and lead to a better understanding of the role of mitophagy in health and disease.

In Vitro and In Vivo Detection of Mitophagy in Human Cells, C. Elegans, and Mice

Mitophagy, the process of clearing damaged mitochondria, is necessary for mitochondrial homeostasis and health maintenance. This article presents some of the latest mitophagy detection methods in human cells, Caenorhabditis elegans, and mice.

Mitochondria are the powerhouses of cells and produce cellular energy in the form of ATP. Mitochondrial dysfunction contributes to biological aging and a ...

Methodology for Sputum Induction and Laboratory Processing

The technique of sputum induction and processing is a recognized non-invasive method allowing the collection and analysis of cells from the airways, which is interesting in various respiratory diseases like asthma, chronic obstructive pulmonary disease (COPD), chronic cough, or idiopathic pulmonary fibrosis. This technique is well tolerated, safe and non-invasive, but is currently limited to research services and specialized centers in clinical practice because it is technically demanding, time-consuming, and requires trained staff. The success rate of sputum induction and analysis is about 80%.
Here, we describe the induction and laboratory processing of sputum samples. Sputum is induced by inhalation of hypertonic or isotonic saline with salbutamol. For the processing, we use the whole sputum technique. Dithiothreitol (DTT) is used to allow mucolysis of sputum samples. The primary aim of sputum processing is to obtain a differential cell count to study the cell types present in the airway lumen. Additional analyses may also be performed on sputum supernatant and sputum cells, which may allow further investigation into inflammatory processes and immune mechanisms. Examples include studying mediators in sputum supernatant and performing a large spectrum of analysis on sputum cells such as flow cytometry, genomics, or proteomics.
Finally, representative results of sputum analysis in healthy controls, asthmatics, and COPD patients are presented.

Here we describe the technique of sputum induction. This protocol also explains the sputum processing to perform a differential cell count and to collect sputum supernatant and cells for further analysis.

The technique of sputum induction and processing is a recognized non-invasive method allowing the collection and analysis of cells from the airways, which ...

The Pilocarpine Model of Temporal Lobe Epilepsy and EEG Monitoring Using Radiotelemetry System in Mice

Temporal lobe epilepsy (TLE) is a common neurological disorder in adulthood. For translational studies of chronic epilepsy, pilocarpine-induced status epilepticus (SE) is frequently selected to recapitulate spontaneous recurrent seizures (SRS). Here we present a protocol of SE induction by intraperitoneal (i.p.) injection of pilocarpine and monitoring of chronic recurring seizures in live animals using a wireless telemetry video and electroencephalogram (EEG) system. We demonstrated notable behavioral changes that need attention after pilocarpine injection and their correlation with hippocampal neuronal loss at 7 days and 6 weeks post-pilocarpine. We also describe the experimental procedures of electrode implantation for video and EEG recording, and analysis of the frequency and duration of chronic recurrent seizures. Finally, we discuss the possible reasons why the expected results are not achieved in each case. This provides a basic overview of modeling chronic epilepsy in mice and guidelines for troubleshooting. We believe this protocol can serve as a baseline for suitable models of chronic epilepsy and epileptogenesis.

This manuscript describes a method of inducing status epilepticus by systemic pilocarpine injection and of monitoring spontaneous recurrent seizures in live animals using a wireless telemetry video and electroencephalogram system. This protocol can be utilized for studying the pathophysiologic mechanisms of chronic epilepsy, epileptogenesis, and acute seizures.

Temporal lobe epilepsy (TLE) is a common neurological disorder in adulthood. For translational studies of chronic epilepsy, pilocarpine-induced status ...